Moderna Therapeutics

Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab
Moderna's gene therapy expansion picks up pace with $76M upfront Generation Bio collab
Fierce Biotech
Moderna Therapeutics
gene therapy
Generation Bio
Flag link:
Moderna CEO defends price of COVID shot at Senate hearing
Moderna CEO defends price of COVID shot at Senate hearing
BioPharma Dive
Moderna Therapeutics
vaccines
COVID-19
drug pricing
Senate
Bernie Sanders
Stephane Bancel
Flag link:
AACR 2023 – Moderna's immunotherapeutic splash
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
Flag link:
Moderna, riding COVID success and busy growing its pipeline, hikes pay of CEO Bancel to $19.4M
Moderna, riding COVID success and busy growing its pipeline, hikes pay of CEO Bancel to $19.4M
Fierce Pharma
Moderna Therapeutics
Pharma CEOs
Stephane Bancel
executive compensation
Flag link:
Moderna adding 2,000 new workers this year
Moderna adding 2,000 new workers this year
Yahoo/Fox Business
Moderna Therapeutics
hirings
Flag link:
Moderna looks to the West Coast for latest expansion
Moderna looks to the West Coast for latest expansion
Endpoints
Moderna Therapeutics
Seattle
San Francisco
Flag link:
Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured
Moderna's COVID vaccine gambit: Hike the price, offer free doses for uninsured
NPR
Moderna Therapeutics
vaccines
COVID-19
drug pricing
Flag link:
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine
Moderna Eyes Accelerated Approval for mRNA Cancer Vaccine
BioSpace
Moderna Therapeutics
MRNA
vaccines
cancer
cancer vaccines
Flag link:
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Moderna selects Oxfordshire as location for U.K.-based mRNA manufacturing facility
Medical Marketing and Media
Moderna Therapeutics
MRNA
UK
drug manufacturing
Flag link:
Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report
Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report
Fierce Biotech
Big Pharma
Novo Nordisk
Moderna Therapeutics
Gilead Sciences
BeiGene
Flag link:
Moderna May Be Just Getting Started in This Big Market
Moderna May Be Just Getting Started in This Big Market
Motley Fool
Moderna Therapeutics
vaccines
Flag link:
Spotlight – Cystic fibrosis developers take a deep breath
Spotlight – Cystic fibrosis developers take a deep breath
EP Vantage
cystic fibrosis
MRNA
Vertex Pharmaceuticals
4D Molecular Therapeutics
Arcturus Therapeutics
Arrowhead Pharmaceuticals
Boehringer Ingelheim
Eloxx Pharmaceuticals
Krystal Biotech
Moderna Therapeutics
Oxford BioMedica
ReCode Therapeutics
SpliSense
Sumitomo Pharmaceuticals
Tessera Therapeutics
Flag link:
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Fierce Pharma
Moderna Therapeutics
vaccines
NIAID
COVID-19
Flag link:
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Moderna's Cancer Vaccine Wins An FDA Boon, But Shares Drop On Mixed Earnings
Investors Business Daily
Moderna Therapeutics
earnings
MRNA
vaccines
FDA
cancer vaccines
Flag link:
Moderna's latest genomics move sees it team up with Life Edit to develop new gene editing therapies
Moderna's latest genomics move sees it team up with Life Edit to develop new gene editing therapies
Fierce Biotech
Moderna Therapeutics
genomics
MRNA
ElevateBio
Life Edit Therapeutics
gene editing
Flag link:
BioNTech touts differences with Moderna in race for cancer vaccines
BioNTech touts differences with Moderna in race for cancer vaccines
Endpoints
BioNTech
Moderna Therapeutics
Merck
vaccines
cancer
cancer vaccines
Flag link:
Where Will Moderna Be in 5 Years?
Where Will Moderna Be in 5 Years?
Motley Fool
Moderna Therapeutics
vaccines
MRNA
COVID-19
Flu
Flag link:
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
First FDA-Approved RSV Vaccines Expected Later This Year: The Top Vaccines And Their Effectiveness
Forbes
RSV
vaccines
GSK
Pfizer
Sanofi
Sobi
Moderna Therapeutics
AstraZeneca
JNJ
FDA
Flag link:
Moderna checks a few boxes in phase 3 mRNA flu shot trial, but misses on B strains and safety
Moderna checks a few boxes in phase 3 mRNA flu shot trial, but misses on B strains and safety
Fierce Biotech
Moderna Therapeutics
clinical trials
MRNA
vaccines
Flu
flu vaccines
Flag link:
Bernie Sanders, Moderna CEO Stéphane Bancel set to square off on March 22
Bernie Sanders, Moderna CEO Stéphane Bancel set to square off on March 22
Medical Marketing and Media
Moderna Therapeutics
Senate
Bernie Sanders
Stephane Bancel
Pharma CEOs
vaccines
Flag link:

Pages